PMGC Holdings Inc has announced a definitive license agreement for the commercialization of two key animal health products, EL-22 and EL-32. Under the terms, NorthStrive granted Modulant, a subsidiary, exclusive global rights, excluding Korea, for non-human animal health applications. Modulant will assume full responsibility for the development, manufacturing, and commercialization of these products. This strategic collaboration aims to significantly improve animal muscle health and feed efficiency. The agreement also includes shared ownership of any new intellectual property generated, fostering further innovation. This expansion of PMGC Holdings Inc's product portfolio and market reach in the animal health sector is anticipated to drive increased revenue and market share.
Get AI-powered deep analysis for every story with a paid subscription
Upgrade for Analysis